Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    MALARIA, SUSCEPTIBILITY TO
Show Display Options
Rank Status Study
1 Recruiting Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali
Condition: Malaria
Intervention:
2 Completed Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in Vietnam
Condition: Plasmodium Vivax Malaria
Interventions: Drug: Chloroquine;   Drug: Dihydroartemisinin/Piperaquine
3 Completed Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia
Condition: Falciparum Malaria
Intervention: Drug: artesunate 2 mg/kg/day versus 4 mg/kg/day icm mefloquine
4 Completed Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa
Condition: Drug Resistant Malaria Due to Plasmodium Falciparum
Interventions: Drug: Arthemeter-lumefantrine;   Drug: Artesunate mefloquine;   Drug: Dihydroartemisinin piperaquine;   Drug: Paracetamol;   Drug: Amoxicillin;   Drug: Quinine
5 Completed Study of Malaria Treatment at Phuoc Long Hospital, Binh Phuoc Province, Vietnam
Condition: Malaria
Intervention: Drug: Artesunate or dihydroartemisinin-piperaquine
6 Suspended Papua New Guinean Duffy Negativity And Vivax Malar
Condition: Plasmodium Vivax Malaria
Intervention:
7 Completed Exposure of Naive and Pre-immune Subjects to P. Vivax Challenge
Condition: Malaria
Intervention: Biological: P. vivax infected mosquito bites

Study has passed its completion date and status has not been verified in more than two years.